Article Details

Therapeutics Company Octant Secures $80 Million In Series B Funding - Pulse 2.0

Retrieved on: 2022-04-28 00:09:57

Tags for this article:

Click the tags to see associated articles and topics

Therapeutics Company Octant Secures $80 Million In Series B Funding - Pulse 2.0. View article details on hiswai:

Excerpt

Launched in 2017, Octant's platform utilizes synthetic biology, high throughput multiplexed assays, synthetic chemistry, and computation to ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up